Medical Equipment

HPV Testing And Pap Test Market Growth Expected to Reach $8.59 Billion by 2030 with 12.3% CAGR

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The HPV Testing And Pap Test Market Over The Period 2026–2030?

The hpv testing and pap test market size has seen swift expansion in recent years. Forecasts indicate it is poised to expand from $4.83 billion in 2025 to $5.41 billion in 2026, driven by a compound annual growth rate (CAGR) of 12.0%. This historic expansion was fueled by factors including the broadening of cervical cancer screening programs, heightened awareness of women’s health concerns, a rise in the adoption of pap testing, the development of diagnostic laboratory networks, and the establishment of standardized screening protocols.

The hpv testing and pap test market size is projected to experience substantial expansion in the coming years. It will grow to $8.6 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. This anticipated growth during the forecast period is fueled by factors such as the increasing adoption of molecular diagnostic technologies, a rising demand for early cancer detection, the expansion of population-based screening initiatives, the growing utilization of automated laboratory systems, and increased healthcare investments in preventive diagnostics. Key trends expected within this period include a greater embrace of HPV DNA-based screening tests, an increase in the application of liquid-based cytology methods, the growing incorporation of automated diagnostic platforms, the broadening of co-testing approaches for cervical screening, and a heightened emphasis on the precision of early cancer detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10060&type=smp

Which Economic Or Industry Drivers Are Impacting The HPV Testing And Pap Test Market?

The escalating prevalence of cervical cancer is a significant factor propelling the HPV testing and Pap test markets. This condition involves the uncontrolled proliferation of cells within the cervix. The primary reason for the increased incidence of cervical cancer is insufficient routine screening, which hinders the prompt identification and effective treatment of precancerous changes. Early detection, facilitated by HPV testing and Pap tests, is crucial for managing and controlling the spread of cervical cancer. As an illustration, the Cancer Council Australia, a national nonprofit organization based in Australia, reported in May 2025 that in 2023, 231 females in Victoria were diagnosed with invasive cervical cancer, equating to a diagnosis rate of 6.4 cases per 100,000 females. Consequently, this growing prevalence acts as a key driver for the expansion of the HPV testing and Pap test market.

How Is The HPV Testing And Pap Test Market Divided Into Its Major Segments?

The hpv testing and pap test market covered in this report is segmented –

1) By Test Type: HPV Testing, Pap Test

2) By Product: Instruments, Consumables, Services

3) By End User: Hospitals And Clinics, Laboratories, Other End Users

Subsegments:

1) By HPV Testing: High-Risk HPV Testing, HPV Genotyping

2) By Pap Test: Conventional Pap Test, Liquid-Based Pap Test, Pap Plus HPV Testing

How Are Trends Transforming The HPV Testing And Pap Test Market Landscape?

Leading companies in the HPV and Pap test market are concentrating on developing innovative solutions such as rapid, low-cost, and point-of-care screening kits to enhance the early detection and accessibility of cervical cancer testing. These rapid, low-cost, point-of-care screening kits are medical examinations that provide quick results, are affordable, and can be utilized directly in clinics or community settings without requiring complex laboratory infrastructure. For instance, in April 2025, the Department of Biotechnology, an India-based government agency, introduced HPV test kits specifically for cervical cancer screening. These kits enable rapid, point-of-care detection of high-risk HPV genotypes, which are responsible for over 96% of cervical cancer cases, allowing for faster and more accurate screening. They are cost-effective and engineered for deployment in resource-limited environments, thus ensuring widespread accessibility in both rural and urban healthcare facilities. These kits significantly support India’s cervical cancer prevention strategies by offering an economical substitute to traditional screening methods and align with the WHO goal of 70% screening coverage by 2030.

Who Are The Prominent Organizations Shaping The HPV Testing And Pap Test Market?

Major companies operating in the hpv testing and pap test market are Abbott Laboratories, QIAGEN N V, Becton Dickinson and Company, Hologic Inc, F Hoffmann La Roche AG, Seegene Inc, DiaSorin S p A, Genomica S A U, TruScreen Group Limited, Danaher Corporation, Siemens Healthineers AG, bioMérieux SA, Takara Bio Inc, Fujirebio Diagnostics Inc, Randox Laboratories Ltd, Quidel Corporation, Vela Diagnostics, Greiner Bio One International GmbH, Cepheid, Roche Diagnostics International AG, Genedrive plc

Read the full hpv testing and pap test market report here:

https://www.thebusinessresearchcompany.com/report/hpv-testing-and-pap-test-global-market-report

What Are The Top-Performing Regions Within The HPV Testing And Pap Test Market?

North America was the largest region in the HPV testing and Pap test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global HPV testing and Pap tests market report during the forecast period. The regions covered in the hpv testing and pap test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored HPV Testing And Pap Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10060&type=smp

Browse Through More Reports Similar to the Global HPV Testing And Pap Test Market 2026, By The Business Research Company

Human Papillomavirus Hpv Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-papillomavirus-hpv-vaccine-global-market-report

Hpv Associated Disorders Market Report 2026

https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

Cervical Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795